Trial Profile
Non-interventional Study of Avastin in 1st Line Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 May 2013
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms AVANiS
- Sponsors Roche
- 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Sep 2012 New trial record